AGENUS INC
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
AGEN | US
Overview
Corporate Details
- ISIN(s):
- US00847G8042
- LEI:
- Country:
- United States of America
- Address:
- 3 FORBES ROAD, 2421 LEXINGTON
- Website:
- https://agenusbio.com/
- Sector:
- Manufacturing
Description
Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AGENUS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AGENUS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AGENUS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
